| pubmed-article:8393365 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C1519429 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0149925 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0277556 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0242356 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:8393365 | lifeskim:mentions | umls-concept:C0993637 | lld:lifeskim |
| pubmed-article:8393365 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:8393365 | pubmed:dateCreated | 1993-9-2 | lld:pubmed |
| pubmed-article:8393365 | pubmed:abstractText | Survival after relapse or progression of small cell lung cancer (SCLC) is poor. The Southwest Oncology Group (SWOG) initiated a study of modulation of cyclophosphamide (Cy) resistance in this population. At study closure, the value of testing new regimens in previously treated patients was being debated nationally: Is there an independent impact of treatment over favorable prognostic factors? Thus, the authors analyzed the SWOG recurrent SCLC data base. | lld:pubmed |
| pubmed-article:8393365 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8393365 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8393365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8393365 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8393365 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:8393365 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:LivingstonR... | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:Von HoffD DDD | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:O'BryanR MRM | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:CrowleyJ JJJ | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:GriffinBB | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:GandaraDD | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:AlbainK SKS | lld:pubmed |
| pubmed-article:8393365 | pubmed:author | pubmed-author:HutchinsLL | lld:pubmed |
| pubmed-article:8393365 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8393365 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8393365 | pubmed:volume | 72 | lld:pubmed |
| pubmed-article:8393365 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8393365 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8393365 | pubmed:pagination | 1184-91 | lld:pubmed |
| pubmed-article:8393365 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:meshHeading | pubmed-meshheading:8393365-... | lld:pubmed |
| pubmed-article:8393365 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8393365 | pubmed:articleTitle | Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base. | lld:pubmed |
| pubmed-article:8393365 | pubmed:affiliation | Division of Hematology/Oncology, Loyola University Stritch School of Medicine, Maywood, Illinois. | lld:pubmed |
| pubmed-article:8393365 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8393365 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8393365 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:8393365 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8393365 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:8393365 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:8393365 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8393365 | lld:pubmed |
